Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
European Journal of Pharmacology
|
February 1, 2002
Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608)
Will P J M Spooren, Philippe Schoeffter, Fabrizio Gasparini, et al.
BMC Medical Imaging
|
October 17, 2025
Multiparametric MRI assessment of acute neuroinflammation in a murine model of peripheral LPS stimulation
Derya R Shimshek, Stefan Zurbruegg, Anna Neuhaus, et al.
The Journal of Clinical Psychiatry
|
May 13, 2014
Translating molecular advances in fragile X syndrome into therapy: a review
Randi J Hagerman, Vincent Des-Portes, Fabrizio Gasparini, et al.
Parkinsonism & Related Disorders
|
June 22, 2014
Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
Olivier Rascol, Susan Fox, Fabrizio Gasparini, et al.
Neuropharmacology
|
June 13, 2013
Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys
Nicolas Morin, Marc Morissette, Laurent Grégoire, et al.
Journal of Neurochemistry
|
February 6, 2010
Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys
Bazoumana Ouattara, Fabrizio Gasparini, Marc Morissette, et al.
Neuropharmacology
|
January 21, 2012
The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug
Dragos Inta, Dragana Filipovic, Juan M Lima-Ojeda, et al.
Neuropharmacology
|
August 14, 2012
MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates
Nicolas Morin, Laurent Grégoire, Marc Morissette, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 7, 2011
Metabotropic glutamate receptor mGluR5 is not involved in the early hemodynamic response
Novella Calcinaghi, Renaud Jolivet, Matthias T Wyss, et al.
Behavioural Brain Research
|
December 25, 2004
Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion
Carla Bills, Todd R Schachtman, Peter Serfozo, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
European Journal of Pharmacology
|
February 1, 2002
Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608)
Will P J M Spooren, Philippe Schoeffter, Fabrizio Gasparini, et al.
BMC Medical Imaging
|
October 17, 2025
Multiparametric MRI assessment of acute neuroinflammation in a murine model of peripheral LPS stimulation
Derya R Shimshek, Stefan Zurbruegg, Anna Neuhaus, et al.
The Journal of Clinical Psychiatry
|
May 13, 2014
Translating molecular advances in fragile X syndrome into therapy: a review
Randi J Hagerman, Vincent Des-Portes, Fabrizio Gasparini, et al.
Parkinsonism & Related Disorders
|
June 22, 2014
Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
Olivier Rascol, Susan Fox, Fabrizio Gasparini, et al.
Neuropharmacology
|
June 13, 2013
Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys
Nicolas Morin, Marc Morissette, Laurent Grégoire, et al.
Journal of Neurochemistry
|
February 6, 2010
Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys
Bazoumana Ouattara, Fabrizio Gasparini, Marc Morissette, et al.
Neuropharmacology
|
January 21, 2012
The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug
Dragos Inta, Dragana Filipovic, Juan M Lima-Ojeda, et al.
Neuropharmacology
|
August 14, 2012
MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates
Nicolas Morin, Laurent Grégoire, Marc Morissette, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 7, 2011
Metabotropic glutamate receptor mGluR5 is not involved in the early hemodynamic response
Novella Calcinaghi, Renaud Jolivet, Matthias T Wyss, et al.
Behavioural Brain Research
|
December 25, 2004
Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion
Carla Bills, Todd R Schachtman, Peter Serfozo, et al.
Page
of 7